The prognostic significance of T cell receptor β gene rearrangements and idiotype-reactive T cells in multiple myeloma

Leukemia

Volumn 11, Issue 8, 1997, Pages 1312-1317

  Brown, R D ^a   Yuen, E ^a   Nelson, M ^a   Gibson, J ^a   Joshua, D ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Idiotype reactive T cells; Multiple myeloma; Survival; T cell gene rearrangements; T cells

Indexed keywords

IMMUNOGLOBULIN FRAGMENT; IMMUNOGLOBULIN IDIOTYPE; RECEPTOR SUBUNIT;

ARTICLE; CANCER SURVIVAL; FLOW CYTOMETRY; GENE REARRANGEMENT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROGNOSIS; T LYMPHOCYTE RECEPTOR GENE; T LYMPHOCYTE SUBPOPULATION;

EID: 0030923576     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400714     Document Type: Article

References (12)

1. Abbus AK, Perry LL, Bach BA, Greene MI. Idiotype specific T cell immunity, 1. Generation of effector and suppressor T lymphocytes reactive with myeloma idiotype determinants. J Immunol 1980; 124: 1060-1068.
2. Abbus AK. Antigen and T lymphocyte mediated suppression of myeloma cells: model systems for regulation of lymphocyte function. Immunol Rev 1979; 48: 245-264.
3. Lynch RG, Roher JW, Odermatt B. Immunoregulation of murine myeloma cell growth and differentiation: a monoclonal model for B cell differentiation. Immunol Rev 1979; 48: 45-80.
4. Maekawa R, Matsumoto M, Kitagawa T. Effect of recombinant interleukin 2 (r-IL2) on in vivo growth of murine myeloma X5563. Cancer Immunol Immunother 1986; 23: 25-30.
5. Diazani U, Pileri A, Boccadoro M, Palumbo A, Pioppo P, Bianchi A, Camponi A, Fossati G, Battaglio S, Massaia M. Activated idiotype-reactive cells in suppressor/cytotoxic subpopulations of monoclonal gammopathies: correlation with diagnosis and disease status. Blood 1988; 72: 185-191.
6. Osterberg A, Janson CH, Bergenbrandt S, Holm G, Lefvert AK, Wigzell H, Mellstedt H. Peripheral blood T lymphocytes in patients with monoclonal gammopathies: expanded subsets as depicted by capacity to bind to autologous monoclonal immunoglobulins or reactivity with anti-V gene-restricted antibodies. Fur J Haematol 1991; 47: 185-191.
7. Osterberg A, Masucci M, Bergenbrandt S, Holm G. Lefvert AK, Mellstedt H. Generation of T cell clones binding F(ab′)2 fragments of the idiotypic immunoglobulin in patients with monoclonal gammopathy. Cancer Immunol Immunother 1991; 34: 157-162.
8. Bergenbrandt QY, Osterberg A, Osby E, Horn G, Mellestedt H. T cell stimulation induced by idiotypes on monoclonal immunoglobulins in patients with monoclonal gammopathies. Scand J Haematol 1993; 38: 529-534.
9. Holm G, Berganbrandt S, Lefvert AK, Yi Q, Osterberg A, Mellstedt M. Anti-idiotype immunity as a potential regulator in myeloma and related diseases. Ann NY Acad Sci 1991; 636: 178-183.
10. Moss P, Gillespie G, Frodsheim P, Bell J, Reyburn H. Clonal populations of CD4+ and CD8+ T cells in patients with multiple myeloma and paraproteinemia. Blood 1996; 87: 3297-3306.
11. Serra HM, Mant MJ, Ruether BA, Ledbetter JA, Pilarski LM. Selective loss of CD4+CD45R+ T cells in peripheral blood of multiple myeloma patients. J Clin Immunol 1988; 8: 259-265.
12. San Miguel JF, Gonzalez M, Gascon A, Moro MJ, Hernandez JM, Ortega F, Jimenez R, Guerras L, Romero M, Casnova F. Lymphoid subsets and prognostic factors in multiple meyloma. Br J Haematol 1992; 80: 305-309.